Literature DB >> 33291539

Serum Vitamins D, B9 and B12 in Greek Patients with Inflammatory Bowel Diseases.

Aristea Gioxari1, Charalampia Amerikanou1, Efstathia Papada1, Evangelia Zioga1, Andreas D Georgoulis1, George Bamias2, Andriana C Kaliora1.   

Abstract

Deficiencies in vitamin D, folate and cobalamin are common in Inflammatory Bowel Disease (IBD). The aim of the present study was to assess serum levels of these vitamins in IBD adults based on the respective serum cut off values for vitamin deficiencies, and to explore possible associations with IBD-related biomarkers and nutritional intake. A cross-sectional study was carried out and patients with Crohn's disease (CD) or ulcerative colitis (UC) from Attica-Greece were enrolled. Medical and dietary history, clinical examination and blood/stool biomarkers were evaluated. In total, 87 patients participated in the study. Serum levels of 25(OH)D, folate and cobalamin were deficient in 36.8%, 18.4% and 5.7% of patients, respectively. Linear regression analysis in the overall patients showed positive associations between (a) serum 25(OH)D with serum iron (beta = 0.083, p = 0.005) and (b) serum cobalamin with total bilirubin (beta = 0.357, p = 0.020) and direct bilirubin (beta = 0.727, p = 0.033), adjusting for age, sex, body mass index (BMI), disease activity and duration, smoking, nutritional intake and season of recruitment. In CD patients (N = 54), a negative linear association between serum folate and fecal lysozyme was evident (beta = -0.009, p = 0.020). No associations were found for UC patients (N = 33). The serum vitamin profile may be a complementary biomarker for the evaluation of disease activity next to serum and stool inflammatory biomarkers.

Entities:  

Keywords:  IBD; cobalamin; folate; inflammation; oxidative stress; vitamin D

Mesh:

Substances:

Year:  2020        PMID: 33291539      PMCID: PMC7761805          DOI: 10.3390/nu12123734

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  47 in total

1.  Crohn's disease and vitamin B12 metabolism.

Authors:  D Lambert; S Benhayoun; C Adjalla; M A Gelot; P Renkes; F Felden; P Gerard; F Belleville; P Gaucher; J L Guéant; J P Nicolas
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

Review 2.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

Review 3.  Vitamins and Minerals in Inflammatory Bowel Disease.

Authors:  Fayez K Ghishan; Pawel R Kiela
Journal:  Gastroenterol Clin North Am       Date:  2017-10-03       Impact factor: 3.806

4.  Association of intestinal permeability with admission vitamin D deficiency in patients who are critically ill.

Authors:  Ghazaleh Eslamian; Seyed Hossein Ardehali; Melika Hajimohammadebrahim-Ketabforoush; Zahra Vahdat Shariatpanahi
Journal:  J Investig Med       Date:  2019-10-30       Impact factor: 2.895

5.  Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.

Authors:  Yusuf Erzin; Hafize Uzun; Aykut Ferhat Celik; Seval Aydin; Ahmet Dirican; Hulya Uzunismail
Journal:  J Clin Gastroenterol       Date:  2008 May-Jun       Impact factor: 3.062

6.  Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis.

Authors:  T Bernklev; J Jahnsen; E Aadland; J Sauar; T Schulz; I Lygren; M Henriksen; N Stray; O Kjellevold; M Vatn; B Moum
Journal:  Scand J Gastroenterol       Date:  2004-04       Impact factor: 2.423

Review 7.  Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis.

Authors:  Rita Del Pinto; Davide Pietropaoli; Apoorva K Chandar; Claudio Ferri; Fabio Cominelli
Journal:  Inflamm Bowel Dis       Date:  2015-11       Impact factor: 5.325

Review 8.  Vitamin D status: measurement, interpretation, and clinical application.

Authors:  Michael F Holick
Journal:  Ann Epidemiol       Date:  2008-03-10       Impact factor: 3.797

Review 9.  Association between 25(OH)D Level, Ultraviolet Exposure, Geographical Location, and Inflammatory Bowel Disease Activity: A Systematic Review and Meta-Analysis.

Authors:  Chao Lu; Jun Yang; Weilai Yu; Dejian Li; Zun Xiang; Yiming Lin; Chaohui Yu
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

10.  Serum vitamin D but not zinc levels are associated with different disease activity status in patients with inflammatory bowel disease.

Authors:  Nicolae-Catalin Mechie; Eirini Mavropoulou; Volker Ellenrieder; Golo Petzold; Steffen Kunsch; Albrecht Neesse; Ahmad Amanzada
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

View more
  2 in total

1.  A weight-loss Mediterranean diet/lifestyle intervention ameliorates inflammation and oxidative stress in patients with obstructive sleep apnea: results of the "MIMOSA" randomized clinical trial.

Authors:  Michael Georgoulis; Nikos Yiannakouris; Roxane Tenta; Elizabeth Fragopoulou; Ioanna Kechribari; Kallirroi Lamprou; Eleni Perraki; Emmanοuil Vagiakis; Meropi D Kontogianni
Journal:  Eur J Nutr       Date:  2021-04-10       Impact factor: 5.614

Review 2.  Metabolomics as a Promising Resource Identifying Potential Biomarkers for Inflammatory Bowel Disease.

Authors:  Cristina Bauset; Laura Gisbert-Ferrándiz; Jesús Cosín-Roger
Journal:  J Clin Med       Date:  2021-02-06       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.